CLINICAL STUDIES

ORAMED

A Placebo-controlled, Multi-center, Randomized, Phase 2b Study to Evaluate the Efficacy and Safety of ORMD-0801 in Type 2 Diabetes Mellitus Patients with Inadequate Glycemic Control on Oral Therapy

Study Phase:

Phase 2b

Criteria:

  • Male or Female 18 years or older
  • Type 2 Diabetes Mellitus (T2DM)
  • HbA1C ≥ 7.5%.
  • BMI up to 40 kg/m2
  • Taking metformin
Register